Brown Advisory Inc Fibrogen Inc Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$18.57 - $35.68 $14.9 Million - $28.7 Million	-803,993 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $6.44 Million - $11.6 Million	207,791 Added 34.85%	803,993 $27.9 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $7.87 Million - $10.4 Million	212,111 Added 55.22%	596,202 $22.1 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $15.5 Million - $17.5 Million	384,091 New	384,091 $15.8 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.